Stephanie Saw and Jordi Remon
Dec 25, 2024, 15:09
Stephanie Saw: First line and post-progression treatment options for advanced EGFR-mutated NSCLC
Stephanie Saw, Medical Oncologist at National Cancer Center of Singapore, shared a post on X:
“Inspired by my good friend and slide master Jordi Remon – sharing these updated summary slides for 1L and post-progression treatment options for advanced stage EGFR-mutated NSCLC.
Might be outdated soon but hopefully not before 2025.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 25, 2025, 16:56
Feb 25, 2025, 15:10
Feb 25, 2025, 14:12
Feb 25, 2025, 14:04
Feb 25, 2025, 13:56
Feb 25, 2025, 13:46
Feb 25, 2025, 13:38